(INR) Multi Units France - Lyxor - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: FR0010361683 • India Equity
INR: Exchange, Traded, Funds, India, Stocks
The Lyxor MSCI India UCITS ETF (INR) is a France-domiciled exchange-traded fund designed to provide exposure to Indian equities. Listed on Euronext Paris under the ticker symbol INR, this ETF tracks the Morningstar India Total Market Index Net Total Return USD (Morningstar India TME NR USD), offering a broad representation of Indian companies across various market capitalizations. With an AUM of 937.14 million EUR, it is a sizeable fund that attracts both institutional and retail investors seeking access to the Indian growth story.
As a UCITS-compliant ETF, it adheres to European regulatory standards, ensuring transparency and liquidity for investors. The fund is structured to minimize tracking error, with a focus on replicating the performance of its underlying index. This makes it a popular choice for fund managers and investors looking for efficient and cost-effective exposure to the Indian market. The ETFs expense ratio and tracking difference are key metrics to evaluate for potential investors.
Indias equity market has been a focal point for global investors due to its long-term growth potential, driven by demographic trends, economic reforms, and technological advancements. The Morningstar India TME NR USD index captures this growth by including a wide range of Indian companies, providing diversification across sectors such as technology, financials, and consumer goods. Investors in this ETF gain access to both large-cap and mid-cap Indian companies, making it a versatile tool for portfolio allocation.
For investors and fund managers, understanding the ETFs currency exposure is crucial. While the ETF is denominated in EUR, the underlying index is calculated in USD, which means currency fluctuations between the EUR and USD can impact returns. Additionally, the funds liquidity and trading volume are important factors to consider, as they can affect the ease of entering or exiting positions.
Overall, the Lyxor MSCI India UCITS ETF is a compelling option for those seeking to tap into Indias growth trajectory. Its structure, transparency, and focus on a diversified Indian equity market make it a valuable addition to portfolios seeking emerging market exposure. As with any investment, evaluating the funds fees, tracking efficiency, and currency risks is essential for making informed decisions.
Additional Sources for INR ETF
INR ETF Overview
Market Cap in USD | 973m |
Category | India Equity |
TER | 0.85% |
IPO / Inception | 2006-11-07 |
INR ETF Ratings
Growth 5y | 65.7% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -9.19 |
Analysts | - |
Fair Price Momentum | 25.09 EUR |
Fair Price DCF | - |
INR Dividends
No Dividends PaidINR Growth Ratios
Growth Correlation 3m | -96.8% |
Growth Correlation 12m | -1.7% |
Growth Correlation 5y | 89.8% |
CAGR 5y | 15.81% |
CAGR/Max DD 5y | 0.77 |
Sharpe Ratio 12m | 0.45 |
Alpha | -10.51 |
Beta | 0.39 |
Volatility | 15.36% |
Current Volume | 83.7k |
Average Volume 20d | 32.8k |
As of March 14, 2025, the stock is trading at EUR 26.61 with a total of 83,712 shares traded.
Over the past week, the price has changed by -1.65%, over one month by -7.99%, over three months by -17.68% and over the past year by -4.09%.
Yes. Based on ValueRay Analyses, Multi Units France - Lyxor (PA:INR) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INR as of March 2025 is 25.09. This means that INR is currently overvalued and has a potential downside of -5.71%.
Multi Units France - Lyxor has no consensus analysts rating.
According to ValueRays Forecast Model, INR Multi Units France - Lyxor will be worth about 27.5 in March 2026. The stock is currently trading at 26.61. This means that the stock has a potential upside of +3.23%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.5 | 3.2% |